Erkki A Nissinen

This inventor holds 13 USPTO granted patents. Top assignees: Orion-Yhtyma Oy, Orion Corporation. Active years: 1990-2005.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Erkki A Nissinen. Retrieved from https://idiyas.com/inventor/erkki-a-nissinen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 13

% Patents Active = 92.3

Average Co-Inventor Count = 7.4

ph-index = 5

Forward Citations = 218(Granted Patents)

Company Filing History:

Years Active: 1990-2005

Loading Chart...

13 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 6878702 - Anti-inflammatory agents (2005-04-12),

2. 6121303 - Pharmacologically active catechol derivatives (2000-09-19),

3. 5889037 - Pharmacologically active catechol derivatives (1999-03-30),

4. 5614541 - Pharmacologically active catechol derivatives (1997-03-25),

5. 5489614 - Catechol derivatives, their physiologically acceptable salts, esters and (1996-02-06),

6. 5446194 - Pharmacologically active catechol derivatives (1995-08-29),

7. 5362733 - Pharmacologically active catechol derivatives (1994-11-08),

8. 5292771 - Substituted .beta.-diketones and their use (1994-03-08),

9. 5288750 - Substituted .beta.-diketones (1994-02-22),

10. 5283352 - Pharmacologically active compounds, methods for the preparation thereof (1994-02-01),

11. 5185370 - Substituted .beta.-diketones and their use (1993-02-09),

12. 5112861 - Method of treating Parkinson's Disease using pentanedione derivatives (1992-05-12),

13. 4963590 - Pharmacologically active compounds, methods for the preparation thereof (1990-10-16),

Title: **Erkki A Nissinen: The Innovator from Espoo**

Introduction

Erkki A Nissinen is a notable inventor based in Espoo, Finland, recognized for his significant contributions to pharmaceutical science. With a portfolio of 13 patents, his work mainly focuses on anti-inflammatory agents and pharmacologically active compounds that have essential applications in the medical field.

Latest Patents

Nissinen's latest patents illustrate his innovative approach to treatment and prevention of inflammation. One of his notable inventions is centered around anti-inflammatory agents, specifically involving the use of mitochondrial K-channel openers. His research emphasizes the effectiveness of certain compounds that induce apoptosis in inflammatory cells to combat inflammation. Additionally, he has developed pharmacologically active catechol derivatives, characterized by complex chemical formulas that include various groups such as nitro and halogeno, showcasing his expertise in creating compounds with therapeutic potential.

Career Highlights

Throughout his career, Nissinen has held positions in renowned companies, including Orion-yhtyma Oy and Orion Corporation. His experiences in these organizations have contributed to the advancement of pharmaceutical innovations, particularly in the treatment of chronic inflammatory conditions.

Collaborations

In his journey as an inventor, Nissinen has collaborated with esteemed colleagues, such as Reijo J Backstrom and Erkki J Honkanen. These partnerships underline the importance of teamwork in fostering innovation and developing new therapeutic solutions.

Conclusion

Erkki A Nissinen's contributions to the pharmaceutical industry through his numerous patents and collaborations underline his status as a prominent figure in medical innovation. As he continues to explore new avenues in his research, his dedication to enhancing human health remains evident.

Profile summary based on public USPTO records.

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]